| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |